BiotechTube

Ruxolitinib + Lenalidomide + Prednisone

Phase 2Completed
0 watching 0 views this week⚡ Active
49
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Myeloproliferative Diseases

Conditions

Myeloproliferative Diseases

Trial Timeline

Sep 22, 2011 → Sep 5, 2018

NCT ID
NCT01375140

About Ruxolitinib + Lenalidomide + Prednisone

Ruxolitinib + Lenalidomide + Prednisone is a phase 2 stage product being developed by Incyte for Myeloproliferative Diseases. The current trial status is completed. This product is registered under clinical trial identifier NCT01375140. Target conditions include Myeloproliferative Diseases.

Hype Score Breakdown

Clinical
17
Activity
12
Company
7
Novelty
5
Community
5

Clinical Trials (1)

NCT IDPhaseStatus
NCT01375140Phase 2Completed

Competing Products

20 competing products in Myeloproliferative Diseases

See all competitors
ProductCompanyStageHype Score
LY2784544Eli LillyPhase 1
33
LY2784544Eli LillyPhase 1
33
Navitoclax + Ruxolitinib + CelecoxibAbbViePhase 1
33
AUY922NovartisPhase 2
52
Pacritinib + Decitabine + Decitabine and Cedazuridine + AzacitidineSwedish Orphan BiovitrumPhase 2
51
Fedratinib PillBristol Myers SquibbPhase 2
51
VAC85135 + IpilimumabBristol Myers SquibbPhase 1
32
Fedratinib PillBristol Myers SquibbPhase 1
32
Fedratinib Oral Capsule 300 mg + Decitabine 20 mg/m2 + Fedratinib Oral Capsule 400 mgBristol Myers SquibbPhase 1
32
RuxolitinibIncytePhase 2
49
Parsaclisib + Parsaclisib + Ruxolitinib + Parsaclisib + ParsaclisibIncytePhase 2
49
INCA036978 + Standard disease-directed therapyIncytePhase 1
30
RuxolitinibIncytePhase 2
49
Ruxolitinib + Anagrelide + Placebo + PlaceboIncytePhase 2
49
itacitinibIncytePhase 2
49
Ruxolitinib + PlaceboIncytePhase 3
74
INCB160058 + Standard disease-directed therapyIncytePhase 1
30
PemigatinibIncytePhase 2
49
Itacitinib + RuxolitinibIncytePhase 2
49
INCA035784IncytePhase 1
30

Other Products from Incyte

ruxolitinib creamApproved
82
Itacitinib + Placebo + Prednisone + MethylprednisolonePhase 3
74
Povorcitinib + PlaceboPhase 3
74
Ruxolitinib Cream + Vehicle CreamPhase 3
74
Tacrolimus (Tac) + Methotrexate (MTX) + Ruxolitinib (Rux) + Cyclophosphamide + Mycophenolate mofetil (MMF)Phase 3
74